Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 17 Colorectal Neoplasms 11 Neoplasm Metastasis 10 Lung Neoplasms 7 Neoplasms 6 Colonic Neoplasms 6 Pancreatic Neoplasms 4 Carcinoma, Renal Cell 2 Advanced Solid Tumor 2 Solid Tumors 1 Resectable Non-Small Cell Lung Cancer 1 Rectal Neoplasms 1 Kidney Neoplasms 1 Healthy Adults 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Resectable Non-Small Cell Lung Cancer × adagrasib × Clear all

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡